Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Russell-Jones

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Diabetologia|June 3, 2011
Insulin X10 revisited: a super-mitogenic insulin analogueB F Hansen, P Kurtzhals, A B Jensen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2015
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trialsD Russell-Jones, M-A Gall, M Niemeyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2011
Miscoding, misclassification and misdiagnosis of diabetes in primary careS de Lusignan, N Sadek, H Mulnier, et al.
Diabetes, Obesity & Metabolism|December 9, 2025
A novel glucose beta-hydroxybutyrate combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetesD Russell-Jones, V Smout, S Roy, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegalyC E Higham, S Rowles, D Russell-Jones, et al.
Epilepsy Research|April 1, 1990
The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsyP N Patsalos, D Russell-Jones, G Finnerty, et al.
Annals of Clinical Biochemistry|February 5, 2003
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucoseM A Crook, L Goldsmith, P Ameerally, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in FijiansM A Crook, J Miell, P Ameerally, et al.
Clinical Endocrinology|October 27, 2001
Computer assisted learning is an effective way of teaching endocrinologyR I Holt, P Miklaszewicz, I C Cranston, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Diabetologia|June 3, 2011
Insulin X10 revisited: a super-mitogenic insulin analogueB F Hansen, P Kurtzhals, A B Jensen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2015
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trialsD Russell-Jones, M-A Gall, M Niemeyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2011
Miscoding, misclassification and misdiagnosis of diabetes in primary careS de Lusignan, N Sadek, H Mulnier, et al.
Diabetes, Obesity & Metabolism|December 9, 2025
A novel glucose beta-hydroxybutyrate combination improves hypoglycaemia recovery and patient-reported outcomes in type 1 diabetesD Russell-Jones, V Smout, S Roy, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegalyC E Higham, S Rowles, D Russell-Jones, et al.
Epilepsy Research|April 1, 1990
The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsyP N Patsalos, D Russell-Jones, G Finnerty, et al.
Annals of Clinical Biochemistry|February 5, 2003
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucoseM A Crook, L Goldsmith, P Ameerally, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 15, 2003
Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in FijiansM A Crook, J Miell, P Ameerally, et al.
Clinical Endocrinology|October 27, 2001
Computer assisted learning is an effective way of teaching endocrinologyR I Holt, P Miklaszewicz, I C Cranston, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Pageof 4